Notícias05/09/2022 Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE): interim analysis of a randomised, controlled, phase 3, immunobridging trialSummaryBackgroundThe Valneva COVID-19 vaccine (VLA2001; Valneva Austria, Vienna, Austria) is an inactivated whole-virus, adjuvanted SARS-CoV-2 vaccine. We aimed... Repositório Covid-1903/09/2022 Computational screening for investigating the synergistic regulatory potential of drugs and phytochemicals in combination with 2-deoxy-D-glucose against SARS-CoV-2AbstractCOVID-19 disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was declared a global pandemic by the World... Repositório Covid-1901/09/2022 Receita de Viracopos cresce 45% dois anos após autorização para receber produtos farmacêuticosPara farmacêutica EMS, com sede em Hortolândia (SP), aeroporto é considerado estratégico pela proximidade e segurança que traz à operação... Associado em foco01/09/2022 Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron SurgeBACKGROUNDThe oral protease inhibitor nirmatrelvir has shown substantial efficacy in high-risk, unvaccinated patients infected with the B.1.617.2 (delta) variant... Repositório Covid-1931/08/2022 Covid-19 Vaccines — Immunity, Variants, Boostershe coronavirus disease 2019 (Covid-19) pandemic has claimed an estimated 15 million lives, including more than 1 million lives in... Repositório Covid-1929/08/2022 Farmacêutica EMS patrocinará equipe no Rally dos Sertões 2022EMS Rally Team, que leva nome do laboratório, irá competir nas categorias UTV2 e UTV3; 30ª edição acontece a partir... Associado em foco24/08/2022 Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risksIntroductionSince its emergence, there have been huge efforts to design vaccines against coronavirus disease 2019 (COVID-19) to inhibit its... Repositório Covid-19 23/08/2022 Estudos sobre vacinas, drogas em desenvolvimento, drogas tradicionais, protocolos clínicos e suprimentos de IFAs para tratamento da Covid-19Acompanhe as atualizações! Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks24 August 2022 –... Acontece na ABIFINA 22/08/2022 Ministério da Saúde reúne Complexo Industrial em evento sobre políticas públicasABIFINA participou de grupos técnicos que identificaram desafios e soluções para as Parcerias para o Desenvolvimento ProdutivoO Ministério da... Acontece na ABIFINA20/08/2022 Oral Nirmatrelvir and Ritonavir in Nonhospitalized Vaccinated Patients With Coronavirus Disease 2019AbstractBackground Repositório Covid-1919/08/2022 Remdesivir Administration in COVID-19 Patients With Renal Impairment: A Systematic ReviewAbstractBackground: Remdesivir (RDV) is the main antiviral for the treatment of moderate to severe forms of Coronavirus disease 2019... Repositório Covid-1919/08/2022 Potential of FX06 to prevent disease progression in hospitalized non-intubated COVID-19 patients — the randomized, EU-wide, placebo-controlled, phase II study design of IXIONAbstractBackgroundMore than 2.7 million hospitalizations of COVID-19-infected patients have occurred in Europe alone since the outbreak of the... Repositório Covid-19
05/09/2022 Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE): interim analysis of a randomised, controlled, phase 3, immunobridging trialSummaryBackgroundThe Valneva COVID-19 vaccine (VLA2001; Valneva Austria, Vienna, Austria) is an inactivated whole-virus, adjuvanted SARS-CoV-2 vaccine. We aimed... Repositório Covid-19
03/09/2022 Computational screening for investigating the synergistic regulatory potential of drugs and phytochemicals in combination with 2-deoxy-D-glucose against SARS-CoV-2AbstractCOVID-19 disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was declared a global pandemic by the World... Repositório Covid-19
01/09/2022 Receita de Viracopos cresce 45% dois anos após autorização para receber produtos farmacêuticosPara farmacêutica EMS, com sede em Hortolândia (SP), aeroporto é considerado estratégico pela proximidade e segurança que traz à operação... Associado em foco
01/09/2022 Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron SurgeBACKGROUNDThe oral protease inhibitor nirmatrelvir has shown substantial efficacy in high-risk, unvaccinated patients infected with the B.1.617.2 (delta) variant... Repositório Covid-19
31/08/2022 Covid-19 Vaccines — Immunity, Variants, Boostershe coronavirus disease 2019 (Covid-19) pandemic has claimed an estimated 15 million lives, including more than 1 million lives in... Repositório Covid-19
29/08/2022 Farmacêutica EMS patrocinará equipe no Rally dos Sertões 2022EMS Rally Team, que leva nome do laboratório, irá competir nas categorias UTV2 e UTV3; 30ª edição acontece a partir... Associado em foco
24/08/2022 Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risksIntroductionSince its emergence, there have been huge efforts to design vaccines against coronavirus disease 2019 (COVID-19) to inhibit its... Repositório Covid-19
23/08/2022 Estudos sobre vacinas, drogas em desenvolvimento, drogas tradicionais, protocolos clínicos e suprimentos de IFAs para tratamento da Covid-19Acompanhe as atualizações! Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks24 August 2022 –... Acontece na ABIFINA
22/08/2022 Ministério da Saúde reúne Complexo Industrial em evento sobre políticas públicasABIFINA participou de grupos técnicos que identificaram desafios e soluções para as Parcerias para o Desenvolvimento ProdutivoO Ministério da... Acontece na ABIFINA
20/08/2022 Oral Nirmatrelvir and Ritonavir in Nonhospitalized Vaccinated Patients With Coronavirus Disease 2019AbstractBackground Repositório Covid-19
19/08/2022 Remdesivir Administration in COVID-19 Patients With Renal Impairment: A Systematic ReviewAbstractBackground: Remdesivir (RDV) is the main antiviral for the treatment of moderate to severe forms of Coronavirus disease 2019... Repositório Covid-19
19/08/2022 Potential of FX06 to prevent disease progression in hospitalized non-intubated COVID-19 patients — the randomized, EU-wide, placebo-controlled, phase II study design of IXIONAbstractBackgroundMore than 2.7 million hospitalizations of COVID-19-infected patients have occurred in Europe alone since the outbreak of the... Repositório Covid-19
